|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | (2006.01) |
| A61K 38/4893 | (2013.01) | ||
| C12N 9/52 | (2006.01) | ||
| C12Y 304/24069 | (2013.01) | ||
| C12N 15/00 | (2006.01) | ||
| C12N 9/52 | (2013.01) | ||
| C12N 15/00 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3694540 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18797284.9 |
| Date of filing the European patent application | 2018-10-11 | |
| (97) | Date of publication of the European application | 2020-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2024-11-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/055379 |
| Date | 2018-10-11 |
| (87) | Number | WO 2019/075182 |
| Date | 2019-04-18 |
| (30) | Number | Date | Country code |
| 201762572159 P | 2017-10-13 | US |
| (72) |
JOHNSON, Eric , US
MORITZ, Molly , US
PELLETT, Sabine , US
BRADSHAW, Marite , US
TEPP, William , US
|
| (73) |
Wisconsin Alumni Research Foundation ,
614 Walnut Street, Madison, WI 53726,
US
|
| (54) | BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE |
| BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE |